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external elastic membrane >1.05.
Results: All TOI showed TIMI thrombus grade 5; however, grade 1 was most frequent
in POI (Gr 0, n=5; Gr 1, n=17; Gr 2, n=12; Gr 3, n=9; Gr 4, n=2; and Gr 5, n=0). Vessel
size, lesion length, plaque burden, minimal lumen area (MLA), and remodeling index
were similar in TOI vs POI (Table). Plaque rupture was present in 48 pts: 27 TOI and
21 POI (p=0.3). Ruptured plaque cavity size was similar (0.81±0.78mm2 in TOI vs
0.93±0.81mm2 in POI, p=0.7). The incidence of VH-TCFAs tended to be higher in
TOIs [51% (34/67)] vs POI [27%(12/45), p=0.12]; %dense calcium within the culprit
lesions was larger in TOI vs POI (p=0.04); and peak troponin I was higher in TOI than
POI (366±218 mg/dl vs 156±260 mg/dl, p=0.012).
Conclusion: Totally-occluded IRAs in STEMI pts are associated with more culprit
lesion calcium and VH-TCFA morphology and greater myonecrosis indicating a higher
risk profile.
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Background: Reduced blood pressure (BP) decreased the cardiovascular events as
well as coronary plaque in patients with hypertension. An inverse relationship between
diastolic pressure and adverse cardiac ischemic events has been observed in numerous
studies. However, the association between BP and coronary plaque regression remains
unclear. We hypothesized that BP reduction with CCB could be correlated with
coronary plaque of hypertensive patients after percutaneous coronary intervention as
post hoc analysis from ALPS-J.
Methods: ALPS-J was designed to evaluate the impact of CCB therapy on plaque
volume in hypertensive patient. Subjects were randomly assigned to receive 16mg/day
of azelnidipine or 5mg/day of amlodipine administered for 48 weeks. Changes in
atheroma burden during 10 months monitored by intravascular ultrasound were studied.
115 patients were completely assessed at baseline and 10-months IVUS data. The
percentage change in plaque volume showed a significant regression of -4.67 and -
4.85% in azelnidipine and amlodipine, respectively. In this sub-analysis, the
relationship between BP and coronary plaque volume was examined. Patients were
divided according to the four quantiles of level of systolic and diastolic BP, and
coronary plaque volume were assigned to 4 groups.
Results: There is no relationship between systolic or diastolic BP and plaque volume.
There was a 4% increase in the plaque volume when the diastolic BP was <70 mm Hg
compared with >70 mm Hg (5% decrease). A J shaped curve association existed
between BP and plaque volume, with lowest plaque regression in the BP range of
approximately 70 mm Hg diastolic.
Conclusion: This is the first study to demonstrate a J-shaped curve association existed
between BP and coronary plaque regression, with lowest coronary plaque volume in
the BP range of approximately 70mm Hg diastolic, which suggests that too low of a
pressure (especially less than70 mm Hg) may be dangerous.
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Background: Plaque composition and plaque growth are affected by multiple factors.
Among them, the role of endothelial wall shear stress(EWSS), however, on vulnerable
plaque growth is not well studied.
Methods: We evaluated coronary CT angiography and virtual histology intravascular
ultrasound(VH-IVUS) image data on left anterior descending artery(LAD) from six
patients with thin-cap fibroatheroma(TCFA) and 6 patients with non-TCFA. We
performed volumetric plaque analysis and investigated circumferential 360 degree of
EWSS in vessel wall by computational fluid dynamics.
Results: Pt’s characteristics are as follows: mean age 60.0±8.7 yrs, male 83%, diabetes
17%, unstable angina 92%. There were no significant differences between 2 groups in
vessel area, lumen area, plaque burden, and remodeling index. VH-IVUS showed that
absolute area of fibrofatty component was significant smaller, but absolute area and
relative amount of necrotic core(NC) components were significant larger in TCFA
group than non-TCFA group. Relative amount of NC increased as average
EWSS(r=0.752, p=0.008) and velocity increased(r=0.829, p=0.041) in MLA site.
Average EWSS, oscillatory shear index, and velocity values of proximal reference site,
minimal lumen area site, and distal reference site were not different between 2 groups.
Maximal EWSS, however, was significantly greater in TCFA group than non-TCFA
group(p=0.044)(Table).
Conclusion: EWSS may have influence on plaque growth, especially NC component.
Furthermore, high EWSS potentially contributes to plaque destabilization in advanced
plaques.
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Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to MACE rates as
high as 24% at 30 days, stent malapposition and a number of procedural issues such
as perforation. The Orbit I trial evaluated the safety and performance of the
Diamondback 360 System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN) for the
treatment of de novo calcified coronary lesions.
Methods: The Orbit I study was a prospective, non randomized trial conducted at two
centers in India from May 2008 to July 2008. 50 non-consecutive patients with a de
novo, coronary lesion with stenosis ≥50% and ≤100% and at least one quadrant of
calcification via IVUS, were treated with the OAS prior to stent placement. The
endpoints were safety as measured by MACE rates, TLR, procedural success and
device performance at 6 months.
Results: Of the 50 patients, 90% were male and the average age was 57.4 years. The
ACC/AHA Lesion Class was: Type A 6.0%; Type B1 50.0%; Type B2 44.0%. The
lesion length was 13.4 mm, and the number of devices used per patient was 1.3. The
percent diameter stenosis was 85.6% pre OAS; 40.0% post-OAS. Procedural success
was 94% of patients achieving ≤20% residual stenosis post stent. Device success was
98%, with no device failures. The overall MACE rate was 4% in-hospital (2 non Q-
wave MI); 6% at 30 days (1 additional non Q-wave MI leading to TLR); 8% at 6
months (1 cardiac death). The angiographic complication rate was measured acutely
and resulted in 7 subjects with one event each (4 minor dissections; 1 major dissection;
2 perforations).
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Conclusion: The Orbit I study demonstrates that the OAS offers a safe and effective
method to debulk calcified coronary lesions which continues positive post-procedure.
A new, multicenter, prospective IDE trial (Orbit II) is underway in the U.S. to obtain
further data on the safety and effectiveness of the OAS in severely calcified coronary
lesions.
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Background: Lipid-rich coronary plaques (LCPs) develop during atherosclerosis
progression and underlie most acute coronary syndromes. Recently, a new near-infrared
spectroscopy intravascular system (NIRS) for LCP detection was developed. Since the
natural history of atherosclerosis progression and coronary LCP formation is difficult
to assess in humans, studies in large animal models of atherosclerosis are essential.
We investigated coronary atherosclerosis development in a diseased porcine model by
intracoronary imaging with the NIRS.
Methods: 15 male swine were fed an atherogenic diet for 15 months (M). Serial NIRS
intracoronary imaging was performed at 9, 12 and 15M follow-up (FU); the vascular
segments were matched at the three FU times using side-branches as landmarks (LM,
Fig.).
Results: Data show that the lipid core burden index (LCBI) increases from 9±3A.U.
at 9M to 20±10 respectively 45±28 at 12 and 15M FU (Fig, yellow shows detected
lipid in the vessel wall). The maximal LCBI (corresponding to the worst 10mm within
the imaged segment) indicating the most important LCP also increased from 61±19 at
9M to 114±50 resp. 160±72 at 12 and 15M. Furthermore, the distribution of LCP
probability along the vascular segment increased from distal towards proximal in all
three coronaries.
Conclusion: In conclusion, serial NIRS imaging was able to detect changes in LCP
during disease progression in coronary arteries of atherosclerotic swine. The LCPs
were detected at regions prone to LCP development as acknowledged in humans.
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Background: Our study aims to evaluate the success of rotational atherectomy with a
modified protocol using a platform speed of 135 krpm, pecking technique and a step-
up burr sizing up to a debulking burr-to-artery ratio of greater than 0.6 relative to
conventional stenting procedures without atherectomy by comparing overall long time
survival.
Methods: Out of a 5 year period we selected all 1033 patients treated with single vessel
intervention. 144 cases were excluded because of incomplete data sets. Propensity-
score matching based on 26 clinical and angiographic variables was used to reduce
treatment-selection bias for rotational atherectomy resulting in the formation of 279
matched pairs (i.e. 578 patients). To compare long time survival up to 80 months
Kaplan Mayer curves were calculated.
Results: With respect to postprocedural variables Non-Rota and Rota patients did not
differ significantly regarding final lumen diameter, stent length, number of stents,
percentage of DES and IVUS. Significant differences were found regarding lumen
gain (p=0.009) and percentage of GPIIb/IIIa receptor blocker treatment. Long term
overall survival plots demonstrate a significant advantage for the Rota group (p<0.01)
with a hazard ratio of 0.52 (CI 0.32–0.85). Multivariate Cox regressions showed that
this advantage is not due to differences in GP IIb/IIIa blocker treatment.
Conclusion: With our redefined protocol of rotational atherectomy we could reduce
long-term mortality for matched pairs by 48% on average. We explain this result by
the less traumatizing atherectomy procedure compared to previous trials and the greater
lumen increase assuming a better stent apposition.
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Background: Stent underexpansion is a risk factor for in-stent restenosis (ISR) and
stent thrombosis. Existing techniques to optimize stent expansion are often ineffective
and can be harmful. Implantation of a second stent within an underexpanded stent is
unlikely to correct what is a primary mechanical problem, leading to recurrent
presentations with ISR.
Methods: This study aimed to clarify the effectiveness and feasibility of Excimer Laser
Coronary Angioplasty (ELCA) in improving stent expansion when high pressure non-
compliant balloon (NCB) inflation was ineffective. ECLA ablation was performed at
high energy during contrast injection and only within the under-expnaded stent. The
primary endpoint of optimal stent dilatation was defined as successful stent expansion
using the same NCB which had been unsuccessful prior to ECLA. Secondary endpoints
were the composite of all-cause death, myocardial infarction (MI) and target lesion
revascularization (TLR) at 6-months and defined as Major Adverse Cardiac Events
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